Copper intrauterine contraception for emergency contraception: a prospective multicentre study

World Health Organization (WHO) (Switzerland)0 个研究点目标入组 2,000 人开始时间: 2010年1月19日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Requesting emergency contraception within 120 hour of unprotected intercourse
•2. Regular menstrual cycles (24 to 42 days with no more than 5 days variation)
•3. Having at least one spontaneous cycle before current cycle after recent discontinued hormonal contraception, abortion or delivery
•4. Desire to use IUD as long term contraceptive
•5. Available for follow up in one month, three months and 12 months
•6. Negative pregnancy test
•7. Aged 18 - 44 years

•1. Suspected or confirmed pregnancy
•2. Any episode of pelvic inflammatory disease (PID) or pelvic abscess in the 12 months preceding trial admission
•3. Sexually transmitted infection (STI) within the past six months
•4. Any evidence of STI in clinical or laboratory examination during screening
•5. Multiple sexual partners
•6. Known or suspected genital tract malignancy
•7. Cervical or uterine malformations
•8. Vaginal bleeding of unknown aetiology
•9. Multiple uterine fibroids associated with previous menstrual anomalies
•10. Clinical or laboratory evidence of anaemia (haemoglobin less than 9 g/l)
•11. Unsure about the date of their last menstrual period (LMP needed for pregnancy risk assessment)

发起方

World Health Organization (WHO) (Switzerland)